참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| 반응물 | Monobasic potassium phosphate | HCID 516951 | — |
| 반응물 | 2-(Dicyclohexylphosphino)biphenyl | HCID 2734216 | — |
| 반응물 | 4-Chloro-N-(tert-butyldimethylsilyl)indole | HCID 16427096 | — |
| 반응물 | sodium 2-methylpropan-2-olate | HCID 178418730 | — |
| 촉매 | palladium(II) acetate | HCID 167845 | — |
| 용매 | Toluene | HCID 1140 | — |
| 생성물 | N-tert-Butyldimethylsilyl-4-(4-Boc-piperazinyl)-indole | HCID 22015338 | — |
반응 단계
The compound was prepared according to Method 2 from N-tert-butyldimethylsilyl -4-chloroindole (100 g, 376 mmol, 1 equiv.), tert-butyl 1-piperazinecarboxylate (84 g, 451 mmol), Palladium(II) acetate (1.26 g., 5.62 mmol, 2%), 2-(dicyclohexylphosphino)-biphenyl (3.95 g., 11.28 mmol, 4 mol %), tert-BuONa (50 g, 520 mmol, 1.4 equiv.) in toluene. The solution was cooled to room temperature and KH2PO4 (150 mL, 13% aqueous solution) was added and pH was adjusted (pH=8–9) followed by extraction with toluene (2×100 mL), dried (MgSO4) and evaporated. The residue was crystallized from heptane to yield 124.4 g (79.6%). 1H NMR (CDCl3) δ 7.20 (d, J=8.4 Hz, 1 H), 7.13 (d, J=3.2 Hz, 1 H), 7.06 (t, 1 H), 6.60–6.57 (m, 2 H), 3.65 (t, 4 H), 3.16 (t, 4 H), 1.48 (s, 9 H), 0.91 (s, 9 H), 0.58 (s, 6 H); 13C NMR (CDCl3) δ 155.0; 145.5; 142.2; 129.9; 124.9; 122.0; 109.3; 107.2; 102.9; 79.8; 77.3; 51.5; 28.5; 26.4; 19.5; −3.8; MS (ESI) 416.4 (M+H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07087750B2 |
|---|
| 출처 데이터셋 | uspto-grants-2006_08 |
|---|
| ORD ID | ord-d39b22a8d24447479efd986dc0b1afc9 |
|---|
| 출처 메모 | uspto-grants-2006_08 |
|---|